"Sense Innovation" works exclusively with the eye-tracking device developer Tobii Dynavox as a local expert in Taiwan and is also capable of developing gaze-interaction software. Since 2015, Sense Innovation has been developing various types of eye-tracking softwares that encourage independence for people with disabilities to communicate and work on a computer via eye control. This year, Sense Innovation will showcase a new generation of eye gaze-enabled device, the "TD I-Series," at the Health Care Expo.

TD I-Series is a Windows-based all-in-one device that can be controlled completely with the eyes. It comes in 16-inch and 13-inch screen sizes and can be operable with either the eye control or the touch, or with a mouse or special switches. It includes the built-in eye-control AAC communication software known as TD Snap, enabling therapists to assist patients in eye-tracking speech therapy and making it easier for healthcare providers and aphasic patients to communicate.

We will showcase various mounts paired with the eye-control device on-site, offering a one-stop solution. Additionally, it will be the first public display of "The Eyeland"—an eye-tracking visual perception assessment software—and "The Sense AEye", an eye-tracking E-learning platform complete with teaching materials, tools and resources. Visitors are welcome to come by the booth (J1030) to learn more and try out the products.

This product proposes a personal health guardian: heart health management system and platform with electrocardiogram (ECG) analysis and cardiac disease detection. The system includes front-end IoT-based hardware, a user interface on the smart device’s application (APP), a cloud database, and an AI platform for cardiac disease detection. The front-end IoT-based hardware, a wearable ECG patch with an analog front-end circuit and a Bluetooth module, can detect ECG signals. The APP on smart devices can not only display users’ real-time ECG signals but also label unusual signals instantly and reach real-time disease detection. These ECG signals will be uploaded to the cloud database. The cloud database is used to store each user’s ECG signals, which forms a big-data database for AI algorithms to detect cardiac disease. The classification categories of this model are based on the Advancement of Medical Instrumentation (AAMI) standard to fit the FDA/TFDA regulation and the average accuracy is more than 98.32%. The ECG dataset applied in this product is collected from patients in Tainan Hospital, Ministry of Health and Welfare. Moreover, signal verification was also performed by a cardiologist. The main advantages of this system are real-time monitoring, convenience for wear, and ease of use. This patch has been approved by TFDA (ID: 008050)( https://lmspiq.fda.gov.tw/web/MDPIQ/MDPIQ1000Result?licBaseId=1B7F2D5D-CDCC-4532-84BE-DCF74E65E687 ) with QMS2183. The service iOS APP (https://apps.apple.com/tw/app/yuguard/id6469807344 ) also provides anytime and anywhere arrhythmia monitoring. These can achieve home heart disease care, assist clinics in diagnosing heart diseases, and provide remote heart disease consultations, solving current medical dilemmas and achieving the goal of public health.

To foster the growth of the global exosome industry, BIONET Corp. actively invites international partners to explore various collaboration opportunities and create exosome business prospects together.
BIONET has focused in four areas: "Exosome", "Cell Therapy", "Precision Medicine/Genetic Testing" and "Scientific Informatics".
With 25 years of experience in regenerative medicine, BIONET's exosomes are produced using exclusive nano-purification technology.
Through BIONET Corp.'s exclusive Meta Exosome comprehensive solution, we offer a wide range of exosome R&D and manufacturing services to various industries both domestically and internationally. We are dedicated to our global exosome R&D center and world-class manufacturing hub, providing our partners with high-quality, high-standard, and reliable exosomes at the scale of mass production.

Sandalphon International Inc. and frequency technology experts have jointly launched sleep-aid products to improve sleep quality. Frequency technology reduces disturbances in the sleep environment and promotes the body's natural repair through frequency resonance. It also complements traditional apnea treatments and provides apnea patients with a more comfortable choice.
Hospital caregivers pointed out that apnea can cause a variety of health problems, and traditional treatments often require a long time to adapt. In order to seek a more effective solution that personally used the Sleepbank product in combination and found that it can significantly reduce the discomfort of wearing shallow sleep and the difficulty in returning to sleep after waking up, improving the overall sleep quality.

Taipei, August 26, 2024** — Pioneer Biotech Co., Ltd. today announced that it has secured the exclusive rights from U.S.-based Bio Pleo to distribute its newly developed natural health product, ERAD Plus® tablets, across Asia. The company received Taiwan’s Ministry of Health and Welfare's import approval for the product in June of this year. ERAD Plus® is designed to improve the health of pancreatic beta cells in diabetic patients by enhancing the physiological process known as Endoplasmic Reticulum-Associated Degradation (ERAD). This process helps correct misfolded proinsulin, preventing the accumulation of errors that lead to endoplasmic reticulum stress. ERAD Plus® provides a unique opportunity for protecting and regenerating pancreatic beta cells, slowing the progression of diabetes and working synergistically with existing glucose-lowering medications.

Gene Target, a leading brand in precision health, unveiled its three core technologies—Super Chips, Super Lab, and Super AI—at the latest exhibition, setting a new standard in the biotech industry.

The Super Chips, powered by a database of 5 million Chinese genomes, combined with the fully automated Super Lab, can test over 32 samples in just 3 hours. This system offers high efficiency, low cost, and exceptional precision—delivering the performance of a $3 million lab for just $200,000. Super AI adds an interactive layer, serving as both an educational platform and a market insight tool.

These three innovations create a seamless precision health loop: Super Chips for accurate genetic analysis, Super Lab for enhanced testing efficiency, and Super AI for presenting complex medical technology in an intuitive, interactive way. Gene Target aims to serve 5 million customers worldwide within five years, creating a trillion-dollar business opportunity.

The Charder MA801 utilizes Bioelectrical Impedance Analysis to quickly and safely measure Body Composition Analysis. In addition to full-body and segmental muscle and fat, clinically validated results include cellular health, body water balance, and other advanced indicators of health status.

Visitors to Charder’s booth can receive free scans between 10:00-12:00 and 14:00-16:00 during the exhibition.

GiMialign: The Latest Medical Technology! The Master of Ergonomics! With multiple 20-year invention patents in 43 countries, GiMialign perfectly combines medicine, biomechanics, and technology. Any improper body posture is corrected instantly with GiMialign AI 3D Kinetic Socks.

GiMialign AI 3D Kinetic Socks actively lift the arch, drive muscle contractions, increase kinetic energy, promote circulation, push back the displaced bones of the inner arch, and adjust posture misalignment. Their performance surpasses orthopedic insoles (which only provide passive support when standing still, have no active lifting force, and cannot push back the displaced bones of the inner arch).

Features:

1、Flat feet, leg length discrepancy, and pelvic tilt—corrected in 1 second!
(Instant verification)
2、Performance surpasses orthopedic insoles
3、Long standing, hiking, and running—no back pain or leg fatigue
4、Weight training without improper posture
5、Patented 3D bands counteract incorrect biomechanics
6、The world's only tool for perfect golden arch shaping

The most accurate epigenetic clock is here!